Biomarkers associated with outcomes from OPTIMIZE-1: CD40 agonist mitazalimab with mFOLFIRINOX in patients with untreated metastatic pancreatic cancer.

Authors: Philippe Alexandre Cassier, Jean-Luc Van Laethem, Ivan Borbath, Teresa Macarulla, Karen Paula Geboes, Aurélien Lambert, Hans Prenen, Emmanuel Mitry, Jean-Frédéric Blanc, Jaime Feliú, Roberto A. Pazo Cid, Inmaculada Gallego Jiménez, Karin Enell Smith, Karin Nordbladh, Yago Pico de Coaña, Eileen M. O'Reilly, David Gomez Jimenez, Sumeet Vijay Ambarkhane, Peter Ellmark, Gregory Lawrence Beatty,

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.2624

Source: Full article


Abstract

2624